- Event-Driven TDF/FTC Effective, Affordable HIV PrEP Strategy for Key Populations
- Severe Outcomes in COVID-19 More Likely With Influenza Coinfection
- Fluticasone Furoate Does Not Reduce Time to COVID-19 Symptom Resolution
- Rehabilitation Interventions Aid Post-COVID-19 Condition
- Pneumocystis jiroveci Pneumonia Prophylaxis Associated With Adverse Events in AAV
- Influenza Vaccine Estimated to Be 52% Effective, According to Southern Hemisphere Data
- Increasing Doses May Improve Efficacy of COVID-19 Vaccines in Patients With Cancer
- Cancer Deaths Increased During the First 2 Years of the COVID-19 Pandemic
- Cannabis Reduces T-Cell Activation, Exhaustion, and Senescence in Patients With HIV
- COVID-19 Vaccines Increase PD-L1 Levels, Might Reverse Treatment Resistance in NSCLC
- Early Clean Intermittent Catheterization Recommended With Neurogenic Bladder
- Treatment Failure Down With Standard-Course Therapy in Pediatric UTI
Features
More features
Clinical Tools
Powered by
Powered by 
Can a Breath Test Detect Mesothelioma? It’s Too Soon to Tell.
COVID-19 Vaccines Increase PD-L1 Levels, Might Reverse Treatment Resistance in NSCLC
Predictors of VTE Risk Identified in Patients With Thrombophilia and Cancer
Long COVID May Affect Millions of Americans Never Diagnosed
Azelaic Acid Effectively Treats Rosacea, Acne Vulgaris, and Melasma
